Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Charifson

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|October 1, 1988
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligandsP S Charifson, S D Wyrick, A J Hoffman, et al.
Journal of Clinical Pharmacology|December 1, 1993
Computer-assisted molecular modeling: indispensable tools for molecular pharmacologyJ P Bowen, P S Charifson, P C Fox, et al.
Chemistry & Biology|June 30, 2000
The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivityY Wei, T Fox, S P Chambers, et al.
Journal of Medicinal Chemistry|November 25, 1994
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptorA M Myers, P S Charifson, C E Owens, et al.
Biochemistry|May 27, 1997
Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural studyP S Charifson, L M Shewchuk, W Rocque, et al.
Journal of Medicinal Chemistry|June 20, 1998
Potent dipeptide inhibitors of the pp60c-src SH2 domainG J Pacofsky, K Lackey, K J Alligood, et al.
Chemistry & Biology|March 7, 1998
Identification of peroxisome proliferator-activated receptor ligands from a biased chemical libraryP J Brown, T A Smith-Oliver, P S Charifson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The formation of a covalent complex between a dipeptide ligand and the src SH2 domainK J Alligood, P S Charifson, R Crosby, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Medicinal Chemistry|October 1, 1988
Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligandsP S Charifson, S D Wyrick, A J Hoffman, et al.
Journal of Clinical Pharmacology|December 1, 1993
Computer-assisted molecular modeling: indispensable tools for molecular pharmacologyJ P Bowen, P S Charifson, P C Fox, et al.
Chemistry & Biology|June 30, 2000
The structures of caspases-1, -3, -7 and -8 reveal the basis for substrate and inhibitor selectivityY Wei, T Fox, S P Chambers, et al.
Journal of Medicinal Chemistry|November 25, 1994
Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptorA M Myers, P S Charifson, C E Owens, et al.
Biochemistry|May 27, 1997
Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural studyP S Charifson, L M Shewchuk, W Rocque, et al.
Journal of Medicinal Chemistry|June 20, 1998
Potent dipeptide inhibitors of the pp60c-src SH2 domainG J Pacofsky, K Lackey, K J Alligood, et al.
Chemistry & Biology|March 7, 1998
Identification of peroxisome proliferator-activated receptor ligands from a biased chemical libraryP J Brown, T A Smith-Oliver, P S Charifson, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
The formation of a covalent complex between a dipeptide ligand and the src SH2 domainK J Alligood, P S Charifson, R Crosby, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituentJ E Cobb, S G Blanchard, E G Boswell, et al.
Journal of Medicinal Chemistry|December 4, 1998
N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moietyJ L Collins, S G Blanchard, G E Boswell, et al.
Pageof 2